ReveraGen BioPharma
About:
ReveraGen BioPharma is a small clinical-stage drug development company with a focus on developing therapeutics.
Website: http://www.reveragen.com/
Description:
ReveraGen BioPharma is a small clinical-stage drug development company with a focus on developing therapeutics for Duchenne muscular dystrophy. they run under a venture philanthropy model, through collaborations and partnerships with non-profit foundations and government agencies in both the US and the EU. As such, we keep the focus on stakeholders rather than stockholders.
Total Funding Amount:
$800000
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Rockville, Maryland, United States
Founded Date:
2008-01-01
Contact Email:
eric.hoffman(AT)reveragen.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2018-02-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai